Equities researchers at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a report issued on Monday. The brokerage set a “sell” rating on the stock.
Ampio Pharmaceuticals Stock Up 376.2 %
AMPE stock opened at $0.01 on Monday. Ampio Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $2.47. The business has a fifty day moving average of $0.01 and a two-hundred day moving average of $0.01. The stock has a market cap of $11,400.00, a price-to-earnings ratio of 0.00 and a beta of 3.66.
About Ampio Pharmaceuticals
Featured Articles
- Five stocks we like better than Ampio Pharmaceuticals
- Why Are These Companies Considered Blue Chips?
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
